Kingworld Medicines Group マネジメント
マネジメント 基準チェック /34
現在、CEO に関する十分な情報がありません。
主要情報
Li Sheng Zhao
最高経営責任者
CN¥1.5m
報酬総額
| CEO給与比率 | 98.5% |
| CEO在任期間 | 16.2yrs |
| CEOの所有権 | 54.0% |
| 経営陣の平均在職期間 | データなし |
| 取締役会の平均在任期間 | 14yrs |
経営陣の近況
Recent updates
Kingworld Medicines Group (HKG:1110) Takes On Some Risk With Its Use Of Debt
Oct 04
Kingworld Medicines Group (HKG:1110) Is Increasing Its Dividend To CN¥0.0338
May 31Even With A 26% Surge, Cautious Investors Are Not Rewarding Kingworld Medicines Group Limited's (HKG:1110) Performance Completely
May 22Investors Shouldn't Be Too Comfortable With Kingworld Medicines Group's (HKG:1110) Earnings
Apr 29Kingworld Medicines Group (HKG:1110) Will Pay A Larger Dividend Than Last Year At CN¥0.0338
Apr 23A Look At The Fair Value Of Kingworld Medicines Group Limited (HKG:1110)
Mar 22The Return Trends At Kingworld Medicines Group (HKG:1110) Look Promising
Nov 30Slowing Rates Of Return At Kingworld Medicines Group (HKG:1110) Leave Little Room For Excitement
Aug 17Kingworld Medicines Group (HKG:1110) Will Pay A Larger Dividend Than Last Year At CN¥0.0247
May 30The Returns At Kingworld Medicines Group (HKG:1110) Aren't Growing
May 11Kingworld Medicines Group (HKG:1110) Is Increasing Its Dividend To CN¥0.0247
Apr 03Returns On Capital At Kingworld Medicines Group (HKG:1110) Paint A Concerning Picture
Feb 07A Look At The Fair Value Of Kingworld Medicines Group Limited (HKG:1110)
Oct 07Kingworld Medicines Group's (HKG:1110) Returns On Capital Not Reflecting Well On The Business
Jul 05Kingworld Medicines Group (HKG:1110) Is Increasing Its Dividend To HK$0.024
Apr 27We Like These Underlying Return On Capital Trends At Kingworld Medicines Group (HKG:1110)
Aug 17Kingworld Medicines Group (HKG:1110) Seems To Use Debt Rather Sparingly
Apr 24Returns On Capital Are Showing Encouraging Signs At Kingworld Medicines Group (HKG:1110)
Mar 29Kingworld Medicines Group's (HKG:1110) Shareholders Are Down 46% On Their Shares
Mar 08Are Insiders Buying Kingworld Medicines Group Limited (HKG:1110) Stock?
Feb 15Should You Or Shouldn't You: A Dividend Analysis on Kingworld Medicines Group Limited (HKG:1110)
Jan 25
Will the Promising Trends At Kingworld Medicines Group (HKG:1110) Continue?
Dec 18We Think Kingworld Medicines Group (HKG:1110) Can Stay On Top Of Its Debt
Dec 05What We Learned About Kingworld Medicines Group's (HKG:1110) CEO Compensation
Nov 22CEO報酬分析
| 日付 | 総報酬 | 給与 | 会社業績 |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | CN¥31m |
| Mar 31 2024 | n/a | n/a | CN¥35m |
| Dec 31 2023 | CN¥1m | CN¥1m | CN¥38m |
| Sep 30 2023 | n/a | n/a | CN¥37m |
| Jun 30 2023 | n/a | n/a | CN¥36m |
| Mar 31 2023 | n/a | n/a | CN¥29m |
| Dec 31 2022 | CN¥1m | CN¥1m | CN¥23m |
| Sep 30 2022 | n/a | n/a | CN¥29m |
| Jun 30 2022 | n/a | n/a | CN¥35m |
| Mar 31 2022 | n/a | n/a | CN¥33m |
| Dec 31 2021 | CN¥1m | CN¥1m | CN¥30m |
| Sep 30 2021 | n/a | n/a | CN¥26m |
| Jun 30 2021 | n/a | n/a | CN¥21m |
| Mar 31 2021 | n/a | n/a | CN¥17m |
| Dec 31 2020 | CN¥1m | CN¥1m | CN¥12m |
| Sep 30 2020 | n/a | n/a | CN¥16m |
| Jun 30 2020 | n/a | n/a | CN¥20m |
| Mar 31 2020 | n/a | n/a | CN¥32m |
| Dec 31 2019 | CN¥2m | CN¥2m | CN¥43m |
| Sep 30 2019 | n/a | n/a | CN¥45m |
| Jun 30 2019 | n/a | n/a | CN¥46m |
| Mar 31 2019 | n/a | n/a | CN¥44m |
| Dec 31 2018 | CN¥1m | CN¥1m | CN¥41m |
| Sep 30 2018 | n/a | n/a | CN¥49m |
| Jun 30 2018 | n/a | n/a | CN¥56m |
| Mar 31 2018 | n/a | n/a | CN¥54m |
| Dec 31 2017 | CN¥2m | CN¥1m | CN¥51m |
報酬と市場: Li Shengの 総報酬 ($USD 202.28K ) は、 Hong Kong市場 ($USD 236.00K ) の同様の規模の企業の平均とほぼ同じです。
報酬と収益: Li Shengの報酬は、過去 1 年間の会社の業績と一致しています。
CEO（最高経営責任者
Li Sheng Zhao (66 yo)
16.2yrs
在職期間
CN¥1,452,000
報酬
Mr. Li Sheng Zhao is a Co-founder of Kingworld Medicines Group Limited and serves as its Chief Executive Officer. Mr. Zhao is responsible for Kingworld Medicines Group's overall strategic planning and busi...
取締役
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| Co-Founder | 16.2yrs | CN¥1.45m | 54.04% HK$ 157.1m | |
| Co-Founder & Executive Director | 16.2yrs | CN¥1.32m | 15.23% HK$ 44.3m | |
| Executive Director | 15.3yrs | CN¥483.00k | 0.45% HK$ 1.3m | |
| Independent Non-Executive Director | 14yrs | CN¥285.00k | 0.036% HK$ 103.9k | |
| Independent Non-Executive Director | 14yrs | CN¥285.00k | データなし | |
| Independent Non-Executive Director | 11.3yrs | CN¥285.00k | 0.042% HK$ 121.5k | |
| Independent Non-Executive Director | less than a year | データなし | データなし |
14.0yrs
平均在職期間
61yo
平均年齢
経験豊富なボード: 1110の 取締役会 は経験豊富で 経験豊富 です ( 14年の平均在任期間)。